Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies
Samuel Bitoun, Signe Hässler, David Ternant, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2323098-e2323098
Open Access | Times Cited: 17

Showing 17 citing articles:

Towards Personalized Medicine in Rheumatoid Arthritis
Seema Sharma, James Bluett
Open Access Rheumatology Research and Reviews (2024) Vol. Volume 16, pp. 89-114
Open Access | Times Cited: 7
Deciphering Immunometabolic Landscape in Rheumatoid Arthritis: Integrative Multiomics, Explainable Machine Learning and Experimental Validation
Qiu Dong, Jiayang Wu, Huaguo Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 637-652
Open Access
Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy
Ryan Purdy, Molly John, AE Bray, et al.
Progress in Retinal and Eye Research (2025), pp. 101354-101354
Open Access
Integrating Primary Care and Specialized Therapies in Rheumatoid Arthritis: Optimizing Recognition, Management, and Referral Practices
Dimitrina Miteva, Konstantina Bakopoulou, Ivan Padjen, et al.
Rheumato (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management
Carly Conran, Jason R. Kolfenbach, Kristine A. Kuhn, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 12, pp. 285-294
Closed Access | Times Cited: 12
Long‐Term Follow‐Up of Anti‐Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering
Clarissa Q. Pimentel, Ana Cristina de Medeiros Ribeiro, Andrea Yukie Shimabuco, et al.
Arthritis & Rheumatology (2024)
Closed Access | Times Cited: 3
Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study
Lisa K. Stamp, Paula Keating, Christopher Frampton, et al.
The Journal of Rheumatology (2024) Vol. 51, Iss. 3, pp. 242-249
Closed Access | Times Cited: 2
Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study
Faustino Peron Filho, Andressa de Souza Moreira, A.L.F. Janes, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003992-e003992
Open Access | Times Cited: 2
Biosimilars Versus Originators in Children With Juvenile Idiopathic Arthritis: A Real-World Experience
Maria Francesca Gicchino, Giusy Capasso, Alessia Amodio, et al.
Journal of Pediatric Health Care (2024) Vol. 39, Iss. 1, pp. 88-92
Closed Access | Times Cited: 2
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
Sylvie Rusakiewicz, Svitlana Tyekucheva, S. Tissot-Renaud, et al.
European Journal of Cancer (2024) Vol. 200, pp. 113535-113535
Closed Access | Times Cited: 1
Cutting-edge approaches to B-cell depletion in autoimmune diseases
William H. Robinson, David Fiorentino, Leland W.K. Chung, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Camilla Wibrand, Nini Kyvsgaard, Troels Herlin, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 5, pp. 479-498
Open Access | Times Cited: 1
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis
Wen‐Liang Dong, Xiaowen Hu, Caiying Wu, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152302-152302
Closed Access | Times Cited: 2
The Association between the Response to Rituximab with Sociodemographic Data and Disease Characteristics Among a Sample of Iraqi Patients with Rheumatoid Arthritis
Aya Fawzi Talib, Mohammed Mahmood Mohammed
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 7, Iss. 1(Special), pp. S47-52
Open Access
Immune regulatory and anti‐resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice
Preety Panwar, Pierre Marie Andrault, Dipon Saha, et al.
British Journal of Pharmacology (2024)
Open Access
Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis
Lynn S. zur Bonsen, Daniel Schulze, Steffen E. Künzel, et al.
Journal of Ophthalmic Inflammation and Infection (2024) Vol. 14, Iss. 1
Open Access
Novel insights into the management of rheumatoid arthritis: one year in review 2024
Emanuele Molteni, Antonella Adinolfi, Valentina Bondi, et al.
Clinical and Experimental Rheumatology (2024)
Open Access
Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays
Xiaoliang Ding, Ling Xue, Mingjun Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Therapeutic Monoclonal Antibody─Antidrug Antibody Affinity Constant Determination Using Capillary Electrophoresis–Tandem Mass Spectrometry
Tessa Reinert, Pascal Houzé, Nathalie Mignet, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 49, pp. 19286-19293
Closed Access
Page 1

Scroll to top